Thor Medical raises NOK 10m in share offering

Thor Medical ASA has registered a NOK 10 million capital increase with Norwegian authorities following a 4,000,000-share subsequent offering.

The registration brings the company's total share capital to NOK 70,597,184, comprising 352,985,920 shares.

Thor Medical specializes in supplying radionuclides, particularly alpha particle emitters, using a proprietary production process that avoids irradiation or nuclear reactors.